Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications
Acronym
SYNTHIA
Description of the granted funding
SYNTHIA is an ambitious collaboration between public and private institutions to facilitate the responsible use of Synthetic Data (SD) in healthcare applications. The project will improve the methodological and technical aspects of SD Generation (SDG) by developing new techniques and advancing established ones for different data modalities, including genomics and imaging, to improve the generation of realistic multimodal and longitudinal data.
This project will provide the research community with approaches for transparent benchmarking of alternative SDG methods for specific applications, identify and establish evaluation metrics and methodologies, and contribute to the standardisation of an evaluation assessment framework for SD. Robust evidence of SD applicability in a set of use cases across a broad spectrum of medical conditions will be crucial to demonstrate the potential of SD to accelerate data-driven solutions of equivalent quality to those derived from real patient data. Furthermore, legal and regulatory implications of SD use will be analysed with the aim of delivering an assurance framework to guide secure SD utilization in healthcare.
These significant breakthroughs will be implemented through the open SYNTHIA federated platform, facilitating responsible SD use by the health research community. The platform will facilitate users´ long-term access to extensively validated, reusable synthetic datasets, as well as to SDG workflows and SD assessment frameworks. The federated infrastructure will rely on extended open-source frameworks for interoperability with other data-sharing infrastructures in the context of the European Health Data Space.
A multidisciplinary collaboration of SDG developers, FAIR data experts, clinical researchers, developers of therapies and data-based tools, legal experts, socio-economic analysts, regulatory, policy advocacy, and communication experts will provide a 360º vision on how to advance healthcare applications through SD use.
Show moreStarting year
2024
End year
2029
Granted funding
GE Healthcare IITS USA Corp. (US)
Participant
Wipro GE Healthcare Private Ltd. (IN)
Participant
TRAIN SRL (IT)
230 750 €
Participant
GE HEALTHCARE GMBH (DE)
153 000 €
Third party
PFIZER INC (US)
Participant
European Alliance for Personalised Medicine (SI)
257 500 €
Participant
GATES VENTURES LLC (US)
Participant
GE HEALTHCARE MAGYARORSZAG KFT (HU)
225 000 €
Third party
PFIZER PHARMA GMBH (DE)
Participant
GENERAL ELECTRIC HEALTHCARE ESPANA SA (ES)
120 000 €
Third party
MATICAL INNOVATION SL (ES)
890 125 €
Participant
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE (ITTM) SA (LU)
432 500 €
Participant
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA (BE)
497 500 €
Participant
PATVOCATES GMBH (DE)
158 250 €
Participant
AZIENDA UNITA' SANITARIA LOCALE DI BOLOGNA (IT)
121 052.5 €
Third party
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (UK)
Participant
AZIENDA OSPEDALIERO UNIVERSITARIA POLICLINICO S. ORSOLA MALPIGHI (IT)
112 818.75 €
Third party
GE MEDICAL SYSTEMS SCS (FR)
560 000 €
Participant
BRISTOL-MYERS SQUIBB COMPANY CORP (US)
Participant
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (ES)
249 375 €
Participant
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA (ES)
1 812 018.75 €
Coordinator
JANSSEN PHARMACEUTICA NV (BE)
Participant
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS (EL)
418 125 €
Participant
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA (ES)
146 875 €
Participant
GE HEALTHCARE LIMITED (UK)
Participant
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (CH)
Participant
BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION (ES)
730 000 €
Participant
HUMANITAS MIRASOLE SPA (IT)
506 250 €
Participant
UNIVERSITAT WIEN (AT)
488 450 €
Participant
DNV AS (NO)
268 750 €
Participant
NOVO NORDISK A/S (DK)
Participant
UNIVERSIDAD POLITECNICA DE MADRID (ES)
520 250 €
Participant
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE)
597 500 €
Participant
EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE)
426 205 €
Participant
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (NL)
507 500 €
Participant
ACADEMISCH ZIEKENHUIS LEIDEN (NL)
509 375 €
Participant
CHARITE - UNIVERSITAETSMEDIZIN BERLIN (DE)
411 385 €
Participant
ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA (IT)
558 310 €
Participant
Amount granted
12 438 775 €
Funder
European Union
Funding instrument
HORIZON JU Research and Innovation Actions
Framework programme
Horizon Europe (HORIZON)
Call
Programme part
Health (11673 Innovative Health Initiative (11695 )
Topic
Maximising the potential of synthetic data generation in healthcare applications (HORIZON-JU-IHI-2023-05-04Call ID
HORIZON-JU-IHI-2023-05 Other information
Funding decision number
101172872
Identified topics
computer science, information science, algorithms